Currently, two anti-tumor drugs—Abraxane® (Bristol-Myers Squibb, Princeton, NJ, USA) and Fyarro® (AADI Bioscience, Pacific Palisades, CA, USA)—are delivered using albumin NPs. Here, ALB is linked to neoplasm.